FDA approves Acadia’s Daybue Stix for Rett syndrome

Daybue Stix’s efficacy and safety are supported by the outcomes from the LAVENDER study. Credit: Acadia Pharmaceuticals Inc./Business Wire.



  • Acadia Daybue Stix